Viewing Study NCT06902792


Ignite Creation Date: 2025-12-24 @ 3:44 PM
Ignite Modification Date: 2025-12-28 @ 2:39 PM
Study NCT ID: NCT06902792
Status: ENROLLING_BY_INVITATION
Last Update Posted: 2025-03-30
First Post: 2025-03-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Adebrelimab Combined With Trametinib in the Treatment of Refractory Recurrent Langerhans Cell Histiocytosis in Children and Adolescents
Sponsor: Second Affiliated Hospital of Wenzhou Medical University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module